However, the duration of ongoing treatment depends on individual weight loss goals, response to the medication, and any potential side effects
You may find that you have more energy in the morning or the afternoon
March 30, 2023
According to American Diabetes Association 2022 recommendations, GLP-1RAs with or without metformin are appropriate initial treatment for patients with T2DM with or at high risk for atherosclerotic cardiovascular disease, heart failure, and/or chronic kidney disease [74]
And it's a series of studies with different designs and populations to look, in randomized controlled trials that's the highest level evidence at what this drug would do for individuals with obesity, individuals with obesity who also had diabetes, what about if we add intensive lifestyle therapy to it, what would happen if we stopped the medication, what about individuals living with arthritis or with heart failure or heart disease
It could indicate inadequate caloric intake, nutritional deficiencies, dehydration, or rarely, an underlying condition unmasked by the metabolic changes
